Company: BDRX
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001214659-25-007913
Chunk: 7

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-15
Form: 424B3
Chunk 7
---
 duties levied in connection with the delivery of any Warrant Shares. This letter agreement shall be governed
by the laws of the State of New York without regard to the principles of conflicts of law thereof.

<div align='center'>***************</div>

| 3 |

To accept this offer, Holder
must counter execute this letter agreement and return the fully executed letter agreement to the Company at e-mail: Stephen.stamp@biodexapharma.com,
attention: Stephen Stamp, CEO & CFO, on or before 9:00 am (New York City time) on May 15, 2025.

Please do not hesitate to
call me if you have any questions.

| Sincerely yours,            |
| BIODEXA PHARMACEUTICALS PLC |
| By:                         |
| Name: Stephen Stamp         |
| Title:  CEO & CFO           |

| 4 |

Accepted and Agreed to:

Name of Holder: ________________________________________________________

Signature of Authorized Signatory of Holder:
_________________________________

Name of Authorized Signatory: _______________________________________________

Title of Authorized Signatory: ________________________________________________

Warrant Shares: __________ Series E Warrant Shares
_________ Series H Warrant Shares___________________ __________ Series J Warrant Shares __________ Series K Warrant Shares

Number of Warrants being exercised contemporaneously
with signing this letter:

_____________ Series E Warrants

_____________ Series H Warrants

_____________ Series J Warrants

_____________ Series K Warrants

Aggregate Exercise Price of the Warrants being
exercised contemporaneously with signing this letter: $___________________

DTC Instructions:

The Existing Warrant Shares
shall be delivered to the following DWAC Account Number:

| Broker Name:       |
| Broker DTC DWAC #: |
| Broker Contact:    |
| Account #:         |

| 5 |

<div align='center'>Annex A – Representations and Warranties</div>

. The Company hereby makes the following representations and warranties to the Holder:

(a). The Warrant Shares have previously been registered for issuance on the Registration Statements and the Company knows of
no reason why such Warrant Shares may not be resold without restrictions under the Securities Act.

(b) . The Company will have the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this letter agreement and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this letter
agreement by the Company and the consummation by the Company of the transactions